% | $
Quotes you view appear here for quick access.

CEL-SCI Corporation Message Board

  • cmegladon cmegladon Sep 30, 2009 1:24 PM Flag

    Co infections a problem...more vaccine news

    WASHINGTON (Reuters) – Many people who have died of swine flu infections in the United States have also had bacterial infections, health officials reported on Wednesday.

    A study of 77 patients who died of the new pandemic H1N1 virus showed 29 percent of them had so-called bacterial co-infections, the U.S. Centers for Disease Control and Prevention reported.

    About half of these had Streptococcus pneumoniae, which can be prevented with a vaccine, the CDC said.

    The CDC has already reported that H1N1, declared a pandemic in June, has become more active as weather cools and schools return from summer breaks. Cases are reported in all 50 states.

    "Our influenza season is off to a fast start and unfortunately there will be more cases of bacterial infections in people suffering from influenza," CDC epidemiologist Dr. Matthew Moore said in a statement.

    "It's really important for people, especially those at high risk for the serious complications from influenza, to check with their provider when they get their influenza vaccine about being vaccinated against pneumococcus."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Don't make light of this. Coinfections represent 20% of the H1N1 deaths!!!!!
      Now they allege almost 50% of the co-infections are pneumonia. The other 50%? various and not all know especially at the time of treatment.
      So how do you fight it?
      An adjuvent that is really not an adjuvent.
      An adjuvent that supercharges the ability of the body's cells to fight the infection.
      Click click....get it?

    • 20% of the deaths were attributed to co infections. Now consider the ramifications of an adjuvent that really isn't an adjuvent (but the medical community will call it that) using LEAPs in conjunction with the treatment for N5N1 or H1N1 as a catalyst for immunotherapy against both infections, no matter what the co-infectious agent is!

0.435+0.010(+2.35%)Sep 26 4:00 PMEDT